webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DGN549

  CAS No.:   Cat No.: BADC-00747 4.5  

DGN549 is an innovative ADC cytotoxin with optimized linker technology, providing efficient payload release and enhanced tumor targeting in antibody-drug conjugates for precision oncology. Keywords: ADC linker, cytotoxin payload, targeted drug conjugate, tumor specificity.

DGN549

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin with Linker
Molecular Formula
C60H61N9O12
Molecular Weight
1100.20
Shipping
Room temperature, or blue ice upon request.
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C
In Vitro
Using TAK-164, an anti-GCC ADC undergoing clinical evaluation, the research show that the lipophilic DNA-alkylating payload, DGN549, penetrates beyond the cell targeted layer in GCC-positive tumor spheroids and primary human tumor xenograft models. The penetration distance is similar to model predictions, where the lipophilicity results in moderate tissue penetration, thereby balancing improved tissue penetration with sufficient cellular uptake to avoid significant washout. These results aid in mechanistic understanding of the interplay between antigen heterogeneity, bystander effects, and heterogeneous delivery of ADCs in the tumor microenvironment to design clinically effective therapeutics.

DGN549 is a novel bioscience product with significant potential in various areas of scientific research and application. Here are some key applications of DGN549:

Cancer Research: DGN549 is employed to inhibit specific signaling pathways implicated in tumor progression and metastasis. By targeting these pathways, researchers can study the mechanisms of cancer cell proliferation and survival. This makes DGN549 an invaluable tool for developing targeted cancer therapies and understanding tumor biology.

Neuroscience: In neuroscience, DGN549 is utilized to probe the role of certain proteins in neurodegenerative diseases like Alzheimer’s and Parkinson’s. By inhibiting or modulating these proteins, scientists can explore their effects on neuronal function and neuroinflammation. This aids in the development of potential treatments and improves our understanding of neurological disorders.

Inflammatory Disease Studies: DGN549 is used to investigate the molecular mechanisms underlying various inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. By modulating inflammatory responses, the compound helps researchers identify therapeutic targets and understand disease pathogenesis. This paves the way for the creation of novel anti-inflammatory drugs.

Biochemical Pathway Analysis: DGN549 plays a crucial role in studying specific biochemical pathways and enzyme activities. Researchers use it to assess the impact on metabolic fluxes and the overall behavior of biochemical networks. This information is critical for optimizing biotechnological processes and designing effective metabolic engineering strategies for various industrial applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload ADC Linker–Payload Conjugation ADC Linker Development Chemical Payload Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Linkers - A Crucial Factor in Antibody–Drug Conjugates Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Macropa-NCS | Indole-C2-amide-C2-NH2 | Aminooxy-PEG2-BCN | Aminooxy-PEG4-alcohol | DC-1 | Maytansinoid DM4 | Fmoc-N-amido-PEG2-acetic acid | NHS-PEG4-azide | Fmoc-Val-Ala-PAB-OH | Modified MMAF-C5-COOH | DGN549
Send Inquiry
Verification code
Inquiry Basket